Issue 28
Get instant access to latest e-book

latest newsRead more...

20

Nov 2017

PeptiDream Announces Discovery Collaboration Agreement with Bayer

PeptiDream Inc a public Kanagawabased biopharmaceutical company announced that it has entered into a multitarget discovery collaboration with Germanybased Bayer AG Under the agreement PeptiDream will use its proprietary Peptide Discovery Platform System PDPS technology to identify macrocyclicconstrained peptides against multiple targets of interest selected…

20

Nov 2017

Chugai's Bispecific Antibody Emicizumab Meets Primary Endpoint in Phase lll Study

Chugai Pharmaceutical Co Ltd announced that the primary endpoint has been met for the global phase lll HAVEN NCT study evaluating emicizumab ACE subcutaneous injection once a week and once every two weeks in patients with hemophilia A years of age or older without inhibitors…

18

Nov 2017

WuXi AppTec Selected by IQVIA Stem Cell Center to Serve as GMP Manufacturer of Advanced Therapies

WuXi AppTec WuXi a leading global pharmaceutical biotechnology and medical device openaccess capability and technology platform company announced that its Advanced Therapy Unit based in Philadelphia has been selected as a manufacturing partner for advanced therapies through the California Institute for Regenerative Medicine CIRM funded…

press releasesRead more...

20

Nov 2017

Biohaven Receives Agreement From FDA on Initial Pediatric Study Plan for Rimegepant, a Second Generation Oral CGRP-Receptor Antagonist for the Acute Treatment of Migraine

Biohaven Pharmaceutical Holding Company Ltd announced that the Company has received agreement from the US Food and Drug Administration FDA on the initial pediatric study plan iPSP for orallydosed rimegepant…

20

Nov 2017

leon-nanodrugs Congratulates its Partner MJR Pharmjet on Receiving Prestigious CPhI Award 2017 for Highly Innovative MicroJet Reactor Technology

The CPhI Pharma Awards are among the most prestigious recognitions within the pharmaceutical industry MJR PharmJet partner of leonnanodrugs GmbH in drug development received one of this years awards for…

20

Nov 2017

Sterilization Technology Market to Reach $7.5 Billion by 2023: P&S Market Research

NEW YORK Nov GLOBE NEWSWIRE According to PS Market Research globalsterilization technology marketis forecasted to attain billion value by growing at a CAGR of during The boost in demand of…

EventsRead more...

20-22

Nov 2017

Food Tech-2017

Madridge Conferences
Crowne Plaza Dubai

TOP ARTICLES

  • 4

    Parenteral Preparations

    INTRODUCTION Parenteral preparations are defined as solutions suspensionsemulsions for injection or infusion powders for injection or infusion gels for injecti..

Knowledge Bank

  • Interviews

    Datwyler Pharma Packaging

    Senior Manager Global Scientific Affairs
    Renaud Janssen PhD is the Senior Manager of Global Scientific Affairs at Datwyler Pharma Packaging He frequently presents on international conferences on subjects related to elastomeric and aluminiumplastic closures for pharmaceutical applications Re..

  • Articles

    Mesoporous Silica Nanoparticles

    Mesoporous Silica Nanoparticles MSNs have attracted great attention over the last decade as a drug delivery system in the fields of biotechnology and Nano medicine due to their unique and adjustable physiochemical properties MSNs were first synthesised by Mobil researchers in and were called Mobil Crystalline Materials MCM Some years later the research group…

  • Techno Trends

    Sanofi and Regeneron’s Cemiplimab Receives FDA "Breakthrough Designation"

    Sanofi and Regeneron announced that Cemiplimab REGN has received FDA Breakthrough Therapy Designation for Advanced Cutaneous Squamous Cell Carcinoma Cemiplimab is an investigational human monoclonal antibody targeting PD It would be used to treat adults with metastatic cutaneous squamous cell carcinoma CSCC and adults with locally advanced and unresectable CSCC the second deadliest skin cancer after melanoma Preliminary results for…

Editorial Section

  • Strategy

    China Biopharma

    China today according to our recent studies is actively growing its domestic industry not only to support its huge domestic demand for high quality therapeutics but also to develop an export market capability The industry is making progress with substantial…

  • Clinical Trials

    Patient Recruitment

    To address the challenges faced in patient recruitment and retention in clinical trials innovative technologies are being utilised in AsiaPacific as well as other regions to optimise the processes involved From patient matching to improving the consent process technology has…

  • Manufacturing

    Continuous Manufacturing

    The urgent need to dramatically improve efficiency and productivity within the pharmaceutical manufacturing sector is in the state of flux With the US FDAs push for moving the pharmaceutical industry into st century reality of…

  • Expert Talk

    The Asian Healthcare Market

    The Asian market is growing rapidly and along with this expansion comes the issue of drug counterfeiting Bernd offers his insight into the key trends affecting this market and what regulatory authorities are expecting manufacturers…

TOP